Accretion Pharmaceuticals Share Price

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of Accretion Pharmaceuticals was laid down, which was started as a Partnership Firm in the name of M/s Accretion Pharmaceuticals, pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is currently located at Ahmedabad, in Sanand District of Gujarat, commenced its manufacturing operations in 2014. Thereafter, the Partnership Firm was converted into a Limited Company in the name of Accretion Pharmaceuticals Limited and a certificate of incorporation dated November 29, 2023 was issued by the Registrar of Companies, Central Registration Centre, for and on behalf of the jurisdictional Registrar of Companies.Presently, Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. either for direct sales, loan licence and/or contract manufacturing.The Company is ISO 9001:2015, ISO 14001:2015 and ISO 22000:2018 certified and is led by a experienced board of directors, and a professional and experienced management team with extensive experience in the pharmaceutical.The Company issued and allotted 29,46,000 equity shares of Rs 10 each by raising Rs 29.75 crores in May, 2025.

As of 20 Jan 2026, Accretion Pharmaceuticals share price is ₹68. The stock opened at ₹71 and had closed at ₹70.8 the previous day. During today’s trading session, Accretion Pharmaceuticals share price moved between ₹68.00 and ₹71.00, with an average price for the day of ₹69.50. Over the last 52 weeks, the stock has recorded a low of ₹53.80 and a high of ₹102.50. In terms of performance, Accretion Pharmaceuticals share price has increased by 5.8% over the past six months and has declined by 14.71% over the last year.